C. Chidiac

Publication List Details

Period

1990 - 1993

Number

7

Co-Authors

A non-comparative, multicentre study of cefepime in the treatment of serious bacterial infections (1993)

Mouton, Y., Chidiac, C., Humbert, G., Leroy, J., Veyssier, P., Modai, J., ...

Multi-resistant strains of Gram-negative bacteria are rapidly emerging as a frequent cause of serious bacterial infection in the hospital environment. Effective treatment must include an antibiotic...

Efficacy, safety and tolerance of parenteral piperacillin/tazobactam in the treatment of patients with lower respiratory tract infections (1993)

Mouton, Y., Leroy, O., Beuscart, C., Chidiac, C., Senneville, E., Ajana, F., ...

An open, non-comparative multicentre study was conducted at 36 sites in six countries to test the efficacy and safety of piperacillin/tazobactam in the therapy of lower respiratory tract infections....

Efficacy of intravenous ofloxacin: a French multicentre trial in 185 patients (1990)

Mouton, Y., Leroy, O., Beuscart, C., Sivery, B., Senneville, E., Chidiac, C., ...

The efficacy of intravenous ofloxacin therapy (200 mg 12-hourly) foUowed, when appropriate, by oral administration of the same dose was evaluated in an open multicentre trial involving 185 patients...

Should Pseudomonas aeruginosa isolates resistant to one of the fluorinated quinolones be tested for the others? Studies with an experimental model of pneumonia.

Chidiac, C, Roussel-Delvallez, M, Guery, B, Beaucaire, G

A clinical isolate of Pseudomonas aeruginosa resistant to pefloxacin (Pef) but susceptible to ciprofloxacin (Cip) was studied to compare the in vitro and in vivo activities of Pef, ofloxacin (Ofl),...

Should Pseudomonas aeruginosa isolates resistant to one of the fluorinated quinolones be tested for the others? Studies with an experimental model of pneumonia.

Chidiac, C, Roussel-Delvallez, M, Guery, B, Beaucaire, G

A clinical isolate of Pseudomonas aeruginosa resistant to pefloxacin (Pef) but susceptible to ciprofloxacin (Cip) was studied to compare the in vitro and in vivo activities of Pef, ofloxacin (Ofl),...